Are investigator-initiated clinical trials becoming an ‘endangered species’?

Marzo-Ortega, H. orcid.org/0000-0002-9683-3407 and De Marco, G. orcid.org/0000-0003-2406-161X (2025) Are investigator-initiated clinical trials becoming an ‘endangered species’? RMD Open: Rheumatic and Musculoskeletal Diseases, 11 (3). e006151. ISSN: 2056-5933

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© Author(s) (or their employer(s)) 2025. This is an open access article under the terms of the Creative Commons Attribution License (CC-BY-NC 4.0).
Dates:
  • Accepted: 4 September 2025
  • Published (online): 18 September 2025
  • Published: 18 September 2025
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > Institute of Molecular Medicine (LIMM) (Leeds) > Section of Musculoskeletal Disease (Leeds)
The University of Leeds > Faculty of Arts, Humanities and Cultures (Leeds) > School of Languages Cultures & Societies (Leeds)
Date Deposited: 15 Jun 2026 10:49
Last Modified: 15 Jun 2026 10:49
Status: Published
Publisher: BMJ
Identification Number: 10.1136/rmdopen-2025-006151
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics

View Altmetric information about this item.


CORE (COnnecting REpositories)